Logo

GeneGo Licenses MetaCore to Velcura for Three Years

Nov 10, 2005

NEW YORK, Nov. 10 (GenomeWeb News) - GeneGo has has licensed its pathway database and data mining software to Velcura Therapeutics for three years, the companies said today.

 

Velcura plans to use the MetaCore product for gene expression analysis and proteomic analysis in bone-related disease research, the companies said.

 

GeneGo and Velcura did not disclose financial details of the agreement.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.